Earlier studies using the first generation tau tracers [18F]AV-1451 and [18F]THK-5351 as well as a recent study using [18F]PM-PBB3 demonstrated tau-PET signals in PSP patients correlated with clinical severity [40, 41]. Here, MAPT is linked to supranuclear palsy, progressive, 1.